Cargando…
Elevated autoantibody content in rheumatoid arthritis synovia with lymphoid aggregates and the effect of rituximab
INTRODUCTION: The purpose of this study was to quantitatively evaluate the contribution of synovial lymphoid aggregates to autoantibody (rheumatoid factor [RF] and anti-cyclic citrullinated peptide [anti-CCP]) and total immunoglobulin (IgG and IgM) production in rheumatoid arthritis (RA) patients an...
Autores principales: | Rosengren, Sanna, Wei, Nathan, Kalunian, Kenneth C, Zvaifler, Nathan J, Kavanaugh, Arthur, Boyle, David L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592782/ https://www.ncbi.nlm.nih.gov/pubmed/18761748 http://dx.doi.org/10.1186/ar2497 |
Ejemplares similares
-
New perspectives on the pathogenesis of rheumatoid arthritis
por: Zvaifler, Nathan J.
Publicado: (1988) -
Metabolomic profiling predicts outcome of rituximab therapy in rheumatoid arthritis
por: Sweeney, Shannon R, et al.
Publicado: (2016) -
IMMUNOREACTANTS IN RHEUMATOID SYNOVIAL EFFUSIONS
por: Zvaifler, Nathan J.
Publicado: (1971) -
Co-expression of CD21L and IL17A defines a subset of rheumatoid synovia, characterised by large lymphoid aggregates and high inflammation
por: McKelvey, Kelly J., et al.
Publicado: (2018) -
Fifty years' experience in resarch for pathogenesis of rheumatoid arthritis.
por: Zvaifler, NJ
Publicado: (2003)